We would love to hear your thoughts about our site and services, please take our survey here.
Guys, rampers , or derampers. It’s going nowhere (COVID). Antibody tests a welcome bonus and probably the future if we’re honest. UK needs the provision for all level of response and manufacture. Well done if you’re in. Might not happen tomorrow or the next day but this firm will hit 500p. Be as patient as you want to be.
Per day. It's a start I guess lol https://twitter.com/Abingdon_Health/status/1428305129548222468?s=19
With a big feck off grin on his face
Hallelujah
genedrive plc
("genedrive" or the "Company")
Antibiotic Induced Hearing Loss update
New clinical guidance in the UK supports assay
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, provides an update on its Antibiotic Induced Hearing Loss ("AIHL") assay.
As announced on the 3 December 2020, an 11 month implementation trial at Manchester University NHS Foundation Trust and and Liverpool Women's Hospital successfully concluded in November 2020. The results of the study will be published in a peer reviewed journal. The study's primary outcomes were very positive, showing genedrive's utility as the world's first rapid genetic test in an emergency care neonatal setting. In excess of 750 babies were tested and 160 hospital staff were trained to provide rapid testing in this critical care setting.
Since completion of the trial, there has been new clinical guidance in the UK1 on the importance of the management of specific genetic mutations and their role in hearing loss as a result of antibiotics ("ototoxicity"). Government and Society guidance are considered a key factor influencing the speed and extent of future adoption. The Company and Inspiration Healthcare Group plc (AIM: IHC), the distribution partner for the AIHL assay, believe this will lead to increased demand for the genedrive AIHL test in the UK. This new government guidance reminds healthcare professionals about the impact of antibiotic related ototoxicity and to consider the need for genetic testing prior to initiation of treatment. genedrive's assay is the only commercial point of care test available for the testing of MT-RNR1, the most important mutation contributing to AIHL in infants.
The launch of the genedrive AIHL assay remains on track for summer 2021 and the Company is enthusiastic about both the commercial prospects and the clinical benefits of this novel test to prevent potential irreversible hearing loss and this test becoming a standard of care. The Company is executing initial stage key opinion leader engagement in the UK alongside Inspriration Healthcare in preparation for commercial launch.
David Budd, CEO of genedrive plc, said: "We had the privilege of working with Manchester University NHS Foundation Trust and Liverpool Women's Hospital throughout 2020 on the first deployment globally of a point of care test system to screen for MT-RNR1 - a mitochondrial mutation closely associated with ototoxicity in infants. Despite the emergence of COVID-19, our clinical partners showed huge dedication in keeping this important project on-track, becoming the first in the world to generate valuable information on the utility of this approach in an emergency care setting. As we see updated guidance and greater awareness to the requirement for genetic testing, we only expect increased interest in our novel assay."
3 month shelf life. Can't stockpile it I'm afraid.
Selling to let in institutional investors. Smart move. Remaining shares will rocket.
Are you sure (screen). Tricky keeping up with them all! It suggests to me that they're out of any potential government deal.
Surescreen LFT available to mass market from 15th of March. Read into that what you will.
Good morning,
I hope you are well?
I have listened to all your feedback and concluded there was potential for a Suresign Professional ANTIGEN saliva test as long as it was affordable to companies etc.
We are now at the final stages with these and they should be available w/c 15th March. Please find attached and below details for you to look over:-
1 x kit comprises of the following :-
20x foiled tests
20x 0.5mL packets of buffer
20x funnel collection devices
20x collection tubes
20x collection tube cap/droppers
20x dropper
20x disposable bags
2x IFU – English
2x Test procedure cards – English
I am now taking further interested parties pre-orders that will take priority when these become available.
NB – this test can only be taken by/supervised by a professional.
I look forward to hearing from you.
£1+ close?
Definitely